Jeito Capital Becomes Key Investor In Nmd Pharma As Part Of A €35 Million New Financing

Jeito Capital (“Jeito”), a leading independent Private Equity firm dedicated to biotech and biopharma, today announces that it has become a key investor as part of a €35 Million new financing round in NMD Pharma. The Danish biotech company is developing breakthrough therapies for patients suffering from severe neuromuscular disorders.